Abstract
Light microscopic and ultrastructural findings in patients suffering from chloroquine-induced cardiomyopathy are reviewed. Based on our own observations in an autopsy case, functional and morphological similarities between chloroquine effects and hereditary lysosomal storage diseases are discussed.
Similar content being viewed by others
Abbreviations
- Cq :
-
Chloroquine
- CMP :
-
Cardiomyopathy
References
Abu-Aisha H, Abu Sabba HMA (1979) Cardiac arrest after intravenous chloroquine injection. J Trop Med Hyg 82:36–37
August C, Holzhausen HJ, Schmidt H, Stiller D, Seidlitz G, Zschiesche M (1990) Diagnostik lysosomaler Speicherkrankheiten. Zentralbl Allg Pathol Anat 136:443–453
Augustijns P, Geusens P, Verbeke N (1993) Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur J Clin Pharmacol 44:407–410
Billingham ME (1979) Some recent advances in cardiac pathology. Hum Pathol 10:367–382
Carpenter S, Karpati G (1986) Lysosomal storage in human skeletal muscle. Hum Pathol 17:683–703
Davies MJ (1984) The cardiomyopathies: a review of terminology, pathology and pathogenesis. Histopathology 8:363–393
Dolman CL, Chang E (1972) Visceral lesions in amaurotic familial idiocy with curvilinear bodies. Arch Pathol Lab Med 94:425–430
Edwards WD (1987) Cardiomyopathies. Hum Pathol 18:625–636
Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, Ratliff NB (1987) Chloroquine neuromyotoxicity. Am J Med 82:447–455
Fabre J, de Freudenreich J, Duckert A (1966) Influence of renal insufficiency on the excretion of chloroquine, phenobarbital, phenothiazines and methacycline. Helv Med Acta 33:307–316
Fox RI (1993) Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 23 [Suppl 1]:82–91
Fox RI, Kang HI (1993) Mechanism of action of antimalarial drugs. Lupus 2 [Suppl 1]:9–12
Gonzales-Noriega A, Grubb JH, Talkad V, Sly WS (1980) Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. Cell Biol 85:839–852
Hughes JT, Esiri M, Oxbury JM, Whitty CWM (1971) Chloroquine myopathy. Q J Med 157:85–93
Iglesias CG, Rodriguez RJJ, Rojo OJM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452
Jackson MJ, Jones DA, Harris EJ (1984) Inhibition of lipid peroxidation in muscle homogenates by phospholipase A-2-inhibitors. Biosci Rep 4:581–587
Kaeser HE (1982) Medikamentös ausgelöstes myasthenisches Syndrom. In: Seitz D, Vogel P (eds) Verhandlungen der Deutschen Gesellschaft für Neurologie, vol II. Springer, Berlin Heidelberg New York, pp 269–276
Klug E (1971) Ultraschallextraktion biologischer Proben. Beitr Gerichtl Med 28:333–339
Kunze K (1982) Medikamentös bedingte Affektionen der Muskulatur. In: Seitz D, Vogel P (eds.) Verhandlungen der Deutschen Gesellschaft für Neurologie, vol II. Springer, Berlin Heidelberg New York, pp 254–267
Kunze K, Kauerz U, Schmoldt A (1987) Drug induced myopathy by hydroxychloroquine. Vet Hum Toxicol 29 [Suppl 2]:59–60
Lansimies E, Laaksonen AL, Juva K (1971) Acute cardiotoxicity of chloroquine and hydroxychloroquine in dogs. Ann Med Exp Bio Fenn 49:45–48
Lie SO, Schofield B (1973) Inactivation of lysosomal function in normal cultured human fibroblasts by chloroquine. Biochem Pharmacol 22:3109–3114
Mackenzie AH (1983) Pharmacologie actions of 4-aminoquinoline compounds. Am J Med 75 [Suppl 1A]:5–10
Mackenzie AH (1983) Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 75 [Suppl 1A]:40–45
Mastaglia FL, Papadimitriou JM, Dawkins RL, Beveridge B (1977) Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. J Neurol Sci 34:315–328
McAllister HA, Ferrans VJ, Hall RJ, Strickman NE, Bossart MI (1987) Chloroquine-induced cardiomyopathy. Arch Pathol Lab Med 111:953–956
McCann WP, Permisohn R, Palmisano PA (1975) Fatal chloroquine poisoning in a child. Pediatrics 55:536–538
McChesney EW (1983) Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 75 [Suppl 1A]:11–18
Miller DR, Khalil SK, Nygard GA (1991) Steady state pharmacokinetics of hydroxochloroquine in rheumatoid arthritis patients. DICP 25:1302–1305
Neville HE, Maunder-Sewry CA, McDougall J, Sewell JR, Dubowitz V (1979) Chloroquine-induced cytosomes with curvilinear profiles in muscle. Muscle Nerve 2:376–381
Nilsson O, Fredmann P, Klinghardt GW (1981) Chloroquineinduced accumulation of gangliosides and phospholipides in skeletal muscle. Eur J Biochem 116:565–571
Oli JM, Ihenacho HNC, Talwar RS (1980) Chronic chloroquine toxicity and heart block. East Afr Med J 57:505–507
Ratliff NB, Estes ML, Myles JL, Shirey EK, McMahon JT (1987) Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 316:191–193
Ridout RM, Decker RS, Wildenthal K (1978) Chloroquine induced lysosomal abnormalities in cultured foetal mouse hearts. J Mol Cell Cardiol 10:175–183
Salmeron G, Lipsky PE (1983) Immunosuppressive potential of antimalarials. Am J Med 75 [Suppl 1A]:19–24
Seitz M (1991) Aktueller Stand der medikamentösen Therapie der chronischen Polyarthritis. Ther Umsch 48:613–623
Tett S (1993) Clinical pharmacokinetics of slow-acting antirheumatic drugs. Clin Pharmacokinet 25:392–407
Tett S, Cutler D, Day R (1990) Antimalarials in rheumatic diseases. Baillieres Clin Rheumatol 4:467–489
Verny C, Gennes C de, Sébastien P, Lê Thi Huong Du, Chapelon C, Piette JC, Chomette G, Godeau P (1992) Troubles de la conduction cardiaque au cours d'un traitment prolonge par chloroquine. Presse Med 21:800–804
Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL (1991) Hydroxychloroquine retinopathy. Am J Ophthalmol 112:528–534
Wray R, Iveson M (1975) Complete heart block and systemic lupus erythematosus. Br Heart J 37:982–983
Zic JA, Horowitz DH, Arzubiaga C, King LE (1991) Treatment of cutaneous sarcoidosis with chloroquine. Arch Dermatol 127:1034–1040
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
August, C., Holzhausen, H.J., Schmoldt, A. et al. Histological and ultrastructural findings in chloroquine-induced cardiomyopathy. J Mol Med 73, 73–77 (1995). https://doi.org/10.1007/BF00270580
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00270580